Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tectonic Therapeutic, Inc.

TECX Clue Score49
United States Fiscal year ends December CIK 0001681087 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alise Reicin
26 Oct 2026
Chief Executive Officer
Exercised, kept
10,000
$2.38
$23.80K
Marc Schwabish
10 Feb 2026
Chief Business Officer
Exercised, kept
4,500
$2.38
$10.71K
Alise Reicin
31 Dec 2025
Chief Executive Officer
Exercised, kept
10,966
$2.38
$26.10K
Peter McNamara
22 Dec 2025
Chief Scientific Officer
Exercised, kept
7,000
$2.98
$20.86K

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 223,420
History held since 22 Jun 2018